Medpace Holdings Inc (MEDP)
Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell
$304.14
Buy
$305.34
$9.18 (+3.10%)
Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries.
Prices updated at 12 May 2025, 15:51 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) | Operating margin (%) | Net margin (%) | EBITDA margin (%) | EBITDA |
---|---|---|---|---|---|
2024 | 31.12 | 21.19 | 19.17 | 22.58 | 476m |
2023 | 27.81 | 17.86 | 14.99 | 19.26 | 363m |
2022 | 29.62 | 19.09 | 16.80 | 20.62 | 301m |
2021 | 28.73 | 17.39 | 15.88 | 19.23 | 220m |
2020 | 30.10 | 18.04 | 15.65 | 20.15 | 187m |
2019 | 28.54 | 14.78 | 11.63 | 17.47 | 150m |
2018 | 30.59 | 14.34 | 10.35 | 19.85 | 140m |
2017 | 40.05 | 14.87 | 8.95 | 25.44 | 111m |
2016 | 40.83 | 12.45 | 3.18 | 23.59 | 99m |
Valuation data table
Year | Price / Sales | Price earnings | Price / Cash flow |
---|---|---|---|
2025 | 4.37 | 22.60 | 16.18 |
2024 | 5.13 | 29.09 | 18.51 |
2023 | 5.50 | 35.98 | 23.70 |
2022 | 6.22 | 32.68 | 26.54 |
2021 | 7.49 | 45.06 | 27.51 |
2020 | 5.86 | 42.31 | 25.00 |
2019 | 3.82 | 33.76 | 17.07 |
2018 | 3.14 | 32.08 | 13.44 |
2017 | 3.44 | 54.12 | 15.19 |
2016 | 3.59 | 159.25 | 16.53 |
Price/Forward earnings (YTD)
24.10
Returns
Debt profile
Returns data table
Year | Return on assets (%) | Return on equity (%) | Return on invested capital (%) |
---|---|---|---|
2024 | 21.52 | 58.41 | 48.93 |
2023 | 18.78 | 59.79 | 46.09 |
2022 | 16.28 | 36.62 | 28.69 |
2021 | 11.89 | 20.63 | 18.10 |
2020 | 11.44 | 18.92 | 17.13 |
2019 | 9.49 | 15.22 | 13.90 |
2018 | 7.60 | 13.34 | 10.58 |
2017 | 4.05 | 7.01 | 5.90 |
2016 | 1.36 | 2.62 | 3.22 |
Debt profile data table
Year | Financial leverage |
---|---|
2024 | 2.54 |
2023 | 2.96 |
2022 | 3.50 |
2021 | 1.74 |
2020 | 1.73 |
2019 | 1.57 |
2018 | 1.64 |
2017 | 1.89 |
2016 | 1.60 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.